Symbol
TRVI on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value per share
Latest Disclosed Shares Owned
15,074,080 shares
Security Ownership %
12%

New Enterprise Associates 16, L.P. ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)

13 Feb 2026 - New Enterprise Associates 16, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15,074,080 shares of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI). This represents 12% ownership of the company. In their previous filing dated 20 Mar 2025, New Enterprise Associates 16, L.P. had reported owning 15,074,080 shares, indicating a new holding.